2025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
Chokri Ben Lamine, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on X about a recent article by Ryan A. Metcalf et al., published in JAMA, adding:
”2025 AABB/ICTMG Platelet Transfusion Thresholds
Nonbleeding chemotherapy / allo-HSCT: transfuse if platelet count is less than 10 × 10⁹/L
Adult critical illness, no major bleeding: transfuse if platelet count is less than 10 × 10⁹/L
Lumbar puncture: transfuse if platelet count is less than 20 × 10⁹/L
CVC insertion at compressible site (IJ/femoral): transfuse if platelet count is less than 10 × 10⁹/L
Interventional radiology:
- Low-risk procedure: transfuse if platelet count is less than 20 × 10⁹/L
- High-risk procedure: transfuse if platelet count is less than 50 × 10⁹/L
- Major non-neuraxial surgery: transfuse if platelet count is less than 50 × 10⁹/L
- Preterm neonate without major bleeding: transfuse if platelet count is less than 25 × 10⁹/L
Autologous SCT or aplastic anemia, nonbleeding adults: routine prophylactic transfusion not recommended
Dengue without major bleeding: platelet transfusion not recommended
Nonoperative ICH with platelet count greater than 100 × 10⁹/L, including antiplatelet use: platelet transfusion is not recommended.
Central-line removal is not specifically addressed; the threshold of less than 10 × 10⁹/L applies to insertion at compressible sites, not to removal.
Clinical bleeding, coagulopathy, medications, catheter site/type, and ability to apply compression should guide removal.
Platelet Transfusion – JAMA 2025.pdf. ”
Title: 2025 AABB and ICTMG International Clinical Practice Guidelines
Authors:Ryan A. Metcalf, Susan Nahirniak, Gordon Guyatt, Aarti Bathla, Sandra K. White, Arwa Z. Al-Riyami, Rachel C. Jug, Ursula La Rocca, Jeannie L. Callum, Claudia S. Cohn, Abe DeAnda, Robert A. DeSimone, Allan Dubon, Lise J. Estcourt, Daniela C. Filipescu, Mark K. Fung, Ruchika Goel, Aaron S. Hess, Heather A. Hume, Richard M. Kaufman, Peter Kranke, Vernon J. Louw, Morten H. Møller, Michael F. Murphy, Jennifer A. Muszynski, Cian J. O’Kelly, Monica B. Pagano, Gopal K. Patidar, Katerina Pavenski, Jacqueline N. Poston, Nabiha H. Saifee, Moritz Stolla, Zbigniew M. Szczepiorkowski, Aaron A. R. Tobian, Raman Uberoi, Jonathan Waters, Brittney Williams, Erica M. Wood, Nicole D. Zantek, Michelle P. Zeller, Brenda J. Grossman, Simon J. Stanworth.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 15:54Hassan Raza: Beyond the 100 Minus Age Rule in Bone Marrow Cellularity
-
Nov 7, 2026, 15:42Andrew Zapfel։ Advancing Sickle Cell Disease Care Through Training, Advocacy and Collaboration
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies
-
Nov 7, 2026, 14:00Farzin Beygui: SOLOTAVI Tests Aspirin Discontinuation After TAVI